DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20222083
Published: 2022-08-29

Psoriasis in resource-limited setting: a case report in a remote area in Indonesia

Suspina Pasande

Abstract


The diagnosis and treatment of psoriasis may be challenging in resource-limited setting. We report a 54-year-old male with the diagnosis of psoriasis vulgaris in the rural area of Papua, Indonesia. The diagnosis was made clinically by a general practitioner due to the absence of diagnostics testing and dermatologists around the area. The patient showed improvements after applying combined ointment of glucocorticoids, emollients, and moisturizers.


Keywords


Psoriasis, Rural, Topical treatment

Full Text:

PDF

References


Gudjonsson J, Elder J. Psoriasis. In: Kang S, Amagai M, Bruckner A, Enk A, Margolis D, MicMichael A, Orringer J, eds. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw-Hill. 2019: 457-497.

van de Kerkhof P, Nestle F. Psoriasis. In: Bolognia J, Schaffer J, Cerroni L, eds. Dermatology. 4th ed. Elsevier. 2018: 138-160.

Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369.

Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397:1301-15.

Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945-60.

Zhao S, Xie B, Li Y, Zhao X, Kuang Y, Su J et al. Smart identification of psoriasis by images using convolutional neural networks: a case study in China. J Eur Acad Dermatology Venereol. 2020;34:518-24.

Pratiwi KD, Damayanti D. Profil Psoriasis Vulgaris di RSUD Dr. Soetomo Surabaya: Studi Retropektif. Berk Ilmu Kesehat Kulit dan Kelamin. 2018;30:248-54.

Brezinski EA, Dhillon JS, Armstrong AW. Economic Burden of Psoriasis in the United States: A Systematic Review. JAMA Dermatol. 2015;151:651-8.

Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018;102:18-20.

Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20:4347.

Santamaría MD, Mondragon NI, Santxo NB, Ozamiz-Etxebarria N. Teacher stress, anxiety and depression at the beginning of the academic year during the COVID-19 pandemic. Glob Ment Heal. 2021;8.

Caiazzo G, Fabbrocini G, Di Caprio R, Raimondo A, Scala E, Balato N, Balato A. Psoriasis, cardiovascular events, and biologics: lights and shadows. Front Immunol. 2018;9:1668.

Yang EJ, Beck KM, Sanchez IM, Koo J, Liao W. The impact of genital psoriasis on quality of life: a systematic review. Psoriasis Targets Ther. 2018;8:41.

Elman SA, Weinblatt M, Merola JF. Targeted therapies for psoriatic arthritis: an update for the dermatologist. In: Seminars in Cutaneous Medicine and Surgery. 2018;37:173-81.

Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J et al. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Arch Dermatol Res. 2018;310:701-10.

Schadler ED, Ortel B, Mehlis SL. Biologics for the primary care physician: Review and treatment of psoriasis. Disease-a-Month. 2019;65:51-90.

Dauden E, Blasco AJ, Bonanad C, Botella R, Carrascosa JM, González‐Parra E et al. Position statement for the management of comorbidities in psoriasis. J Eur Acad Dermatol Venereol. 2018;32:2058-73.